Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine 26-5

  • ID: 3690531
  • Book
  • Region: America, North America, United States
  • 240 Pages
  • Elsevier Health Science
1 of 3

Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 3

Loading
LOADING...

3 of 3
Levine, Ross Memorial Sloan-Kettering Cancer Center.
Note: Product cover images may vary from those shown
4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll